Get startedLog in
    Picture of Recordati Industria Chimica E Farmaceutica SpA logo

    REC — Recordati Industria Chimica E Farmaceutica SpA Income Statement

    0.000.00%
    it flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Recordati Industria Chimica E Farmaceutica SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,4491,5801,8532,0822,342
    Cost of Revenue
    Gross Profit1,0421,1521,2871,4231,600
    Selling / General / Administrative Expenses
    Research And Development
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses9801,0901,4111,5231,709
    Operating Profit469490442560632
    Total Net Non Operating Interest Income / Expense
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes456463401491547
    Provision for Income Taxes
    Net Income After Taxes355386312389417
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income355386312389417
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income355386312389417
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS1.711.91.581.721.98
    Dividends per Share